Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies-Reference-Cited by-同舟云学术

Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies

Published:2010-06 Issue:3 Volume:19 Page:214-218
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Lorusso Vito,Cinieri Saverio,Giampaglia Marianna,Ciccarese Mariangela,Tinelli Andrea,Chiuri Vincenzo,Manca Corrado,Silvestris Nicola,Gasparini Giampiero,Colucci Giuseppe

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference49 articles.

1. Cancer: principles and practice of oncology;De Vita,1993

2. Systemic therapy for advanced breast cancer;Tripathy;Breast J,2004

3. Progress in chemotherapy for metastatic breast cancer;Sledge;Sem Oncol,1992

4. The effect on survival of initial chemotherapy in advanced breast cancer. Polychemotherapy versus single drug;Ahmann;J Clin Oncol,1987

5. Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial;Jassem;J Clin Oncol,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation;Frontiers in Oncology;2022-11-30

2. A Real-World Study on Oral Vinorelbine for the Treatment of Metastatic Breast Cancer;Oncologie;2022

3. Capecitabine/vinorelbine;Reactions Weekly;2019-12

4. Oral or intravenous vinorelbine plus capecitabine in heavily pretreated HER2 negative metastatic breast cancer; similar effect or quality of life?;Breast Cancer Research and Treatment;2019-04-23

5. Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients;Breast Cancer Research and Treatment;2019-03-21